Trial Design Solutions

31. Accelerating Patient Engagement And Recruitment 11/20/2023

    Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.

32. Enable Greater Diversity In Clinical Trials 10/19/2023

    Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.

33. Optimize Your Research Site's Growth And Financial Success 10/25/2022

    Explore how Elligo enhances the site financial process through streamlined, automated, cost-effective solutions.

34. Your Global CRO Partner In Oncology And Hematology 1/14/2025

    Learn about an organization dedicated to providing personalized and adaptive trial solutions and managing complex oncology and hematology clinical trials.

35. Bringing Endocrine And Metabolic Disease Treatments To Market 9/20/2023

    Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.

36. Biorasi Rare and Urgent Disease 9/21/2021

    Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.

37. Early Phase Trials In Australia 9/6/2024

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

38. How To Avoid Costly Study Delays And Mitigate Risks 7/22/2024

    Are you still in doubt about your study protocol or how to determine the sample size? Gain access to free clinical trial budgeting and MedSci consulting services from a leading Eastern European CRO.

39. Elligo's Customizable Solutions For Sponsors 1/17/2023

    With the personalized PatientSelect® and SiteSelect service models and proprietary technology, trials are better equipped to research diagnostics, drugs, biologics, and devices at every phase.

40. Rave RTSM: Direct-To-Patient 10/3/2022

    As the healthcare industry continues to deepen its focus on virtual trials and patient-centricity, the popularity of Direct-to-Patient (DtP) services in the clinical trial setting has grown significantly. Rave RTSM DtP (Randomization and Trial Supply Management Direct to Patient) brings investigational medicinal products (IMP) directly to a patient’s home, bypassing the need for the patient to travel directly to a site.